NSEOutcome of Board Meeting5d ago · 14 Aug 2026, 07:30 pm
Outcome of Board Meeting
Modi Naturals Limited · MODINATUR
✦ AI SummaryResults
Modi Naturals Limited has announced the outcome of its board meeting, where it approved the unaudited financial results for the quarter ended June 30, 2026. The results will be published in newspapers and uploaded on the company's website. The board meeting was held on August 14, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Outcome of Meeting of Board held on 14.08.2026
Attachments (1)
📄pdf
Download →
MODINATURALS_14082026192845_Outcome_of_BM.pdf
View document text
14th August 2026
The Manager The Manager
Corporate Relationship Department Listing Department
BSE Limited National Stock Exchange of India Limited
First Floor, New Trade Wing Rotunda Exchange Plaza, 5th Floor Plot No. C/1, ‘G’ Block,
Building, Phiroze Jeejeebhoy Towers, Bandra- Kurla Complex Bandra, East Mumbai-400
Dalal Street, Fort Mumbai-400001 051
Scrip Code: 519003 Symbol : MODINATUR
Dear Sir / Madam,
Sub: Outcome of the Board Meeting held on 14.08.2026
Re: Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th
June 2026
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“SEBI LODR Regulations”), we wish to inform you that the Board of Directors of the Company at its meeting
held today, 14th August, 2026, has, inter alia, approved the Unaudited Financial Results (Standalone and
Consolidated) of the Company for the quarter ended 30th June, 2026, and took on record the limited review
report of the Statutory Auditors of the Company thereon.
As required under Regulation 33 of the SEBI LODR Regulations, we enclose herewith the Unaudited Financial
Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026, along with the
limited review report thereon.
The said results will be published in the newspapers as required under Regulations 47 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and will be uploaded on the website of the
Company i.e., (www.modinarurals.com)
The meeting of the Board of Directors of the Company commenced at 2:00 pm and concluded at 6:45 pm.
This is for your kind information and records.
Thanking you!
Yours Faithfully,
for MODI NATURALS LIMITED
Rajan Kumar Singh
Company Secretary & Compliance Officer
Encl: as above
B.Chhawchharia & Co. 5. 525, DLF TOWER B, JASOLA DISTRICT CENTRE, JASOLA, NEW DELHI 110025, INDIA
Chartered Accountants TELEFAX (91-11) 4037 8600 @ Web : www.bcco.co.in
Independent Auditor’s Review Report on the Quarterly Unaudited Consolidated
Financial Results of the Company pursuant to the requirement of Regulation 33 of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as
amended
Review Report to
The Board of Directors
M/s MODI NATURALS LIMITED
1. We have reviewed the accompanying statement of unaudited consolidated financial
results of M/s MODI NATURALS LIMITED("the Holding Company™) and its
subsidiary (the Holding Company and its subsidiary together referred to as “the
Group™) for the quarter ended June 30, 2026 being submitted by the Holding
Company pursuant to the requirement of Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended.
2. This statement is the responsibility of the Holding Company’s Management and has
been approved by the holding company’s Board of Directors, has been prepared in
accordance with the recognition and measurement principles laid down in Indian
Accounting Standard 34, (IND AS 34) “Interim Financial Reporting”, specified
under Section 133 of the Companies Act, 2013 as amended read with relevant rules
issues thereunder and other accounting principles generally accepted in India. Our
responsibility is to issue a report on these financial statements based on our review
3. We conducted our review in accordance with the Standard on Review Engagement
(SRE) 2410, Review of interim Financial information performed by the Independent
Auditors of the entity issued by the Institute of Chartered Accountants of India. This
standard requires that we plan and perform the review to obtain moderate assurance
as to whether the financial statements are free of material misstatement. A review is
limited primarily to inquiries of company personnel and analytical procedures
applied to financial data and thus provides less assurance than an audit. We have not
performed an audit and accordingly, we do not express an audit opinion.
4. We also performed procedures in accordance with the SEBI Circular No.
CIR/CFD/CMD/44/2019 dated 29th March, 2019 issued by the SEBI under
regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 as amended, to the extent applicable.
KOLKATA | NEWDELHI | NAGPUR
The Statement includes the results of following entity:
© Wholly Owned Subsidiary:
i. Modi Biotech Private Limited
Based on our review conducted as above, nothing has come to our attention that
causes us to believe that the accompanying statement of unaudited financial results
prepared in accordance with applicable Indian accounting standards and other
recognized accounting practices and policies has not disclosed the information
required to be disclosed in terms of Regulations 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 as amended, including the manner
in which it is to be disclosed, or that it contains any material misstatement.
The review of audited consolidated quarterly and year-to-date financial results for
the period ended March 31, 2026, included in the Statement was carried out and
reported by M/s Doogar & Associates, previous auditor who have expressed
unmodified conclusion vide their review report, which has been relied upon by us
for the purpose of our review of the Statement. Our conclusion is not modified in
respect of this matter.
The review of unaudited consolidated quarterly and year-to-date financial results for
the period ended June 30, 2025 and audit of consolidated financial results for the
quarter and year ended March 31, 2026 included in the Statement was carried out
and reported by M/s Doogar & Associates, previous auditor who had expressed
unmodified conclusion vide their review report and unmodified opinion vide their
audit report, respectively, whose reports have been furnished to us and which have
been relied upon by us for the purpose of our review of the Statement. Our
conclusion is not modified in respect of this matter.
For B. Chhawchharia & Co.
Chartered Accountants
Firm Registration No: 305123E
Bupize.
Abhishek Gupta
Partner
Membership No.: 529082
Place: New Delhi
Date:14™ August, 2026
UDIN: 26520 0 g XEZN LPI229
MODI NATURALS LIMITED
Regd. & Corporate Office: D-54, 2nd Floor, Okhla Induatrial Area, Phase-I, New Delhi-110020
(CIN: L15142DL1974PLTCel0: 00117-341488999)99,, E-mail: cs.mnl@modinaturals.org, Website: www.modinaturals.com,
Statement of Consolidated Un-Audited Financial Results for the Quarter and Year ended 30-06-2026
(X Lakhs, Unless Otherwise Stated)
Consolidated
articatars Quarter Ended Year Ended
30/06/2026 | 31/03/2026 | 30/06/2025 | 31/03/2026
(Unaudited) | _(Audited) | (Unaudited) | (Audited)
1 [Revenue from Operations — 15560.64 24307.51] 15502.66] 7191837
S . 3291 20.75] 3.70) 98.4()
] N o Total Income (1+11) 15527.73| 24328.26] _ 15506.58] _ 72016.72
IV |Expenses T
(a) Cost of materials consumed_ 10325.13 19546.41 10082.5() 52712.27)
(b) Purchases of stock-in-trade - 23581 337.95] 181.24 1924.1
gc,])dCsl::;fi:s!’{trlalld\l:x|(unes of finished goods, work-in-progress — (000.27) 135461 =
(d) Employee benefits expense 816.3 1132.73 74535 3413.78)
(e) Finance costs ) o 299.05 144,61 22586 7783
() Depreciation and amortisation expense 290.18 198.99) 199.48) 80117}
(g) Other expenses - B ) 144673 1733.63 1373.73 6462.60)
Total Expenses (1V) 13932.91] 22206.05| 1416279 6614891
v iteanmd tsax (II1-1V) 159482 212221 1343.79) 5867.61]
VI_|Exceptional items 0.00 485.57] 0.00) 48557
VI [Profit before tax (V+VI) 1594.82 2607.78 1343.79 6353.38
(a) Current 27071 518.37] 177.54 1009.94)
(b) Deferred Tax 73.99 122,09 117.00 315.09
IX_|Profit/ (Loss) for the period (VII - VIIT) 1250.12 1967.36) 1049.25 5028.35)
X _|Other Comprehensive Income
Items that will not be reclassified to profit or loss 6.19) 28,81, (1.65) 298¢
(ii). Income tax relatintgo items that will not be reclassified to
profitor loss
. Income tax relatintgo items that will be reclassified to
profit
[Showing first 8,000 characters — download PDF for full document]